2017
DOI: 10.1002/2211-5463.12223
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells

Abstract: Effective drug combinations have the potential to strengthen therapeutic efficacy and combat drug resistance. Both melatonin and valproic acid ( VPA ) exhibit antitumor activities in various cancer cells. The aim of this study was to evaluate the cell death pathways initiated by anticancer combinatorial effects of melatonin and VPA in bladder cancer cells. The results demonstrated that the combination of melatonin and VPA leads to significant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 59 publications
4
22
0
Order By: Relevance
“…We observe a reduction in mitochondrial content in melatonin treated BeWo cells exposed to H/R, which may indicate heightened levels of mitophagy, and which has been shown to be harmful for cancer cells [44, 45]. Our result showing the decreased mitochondrial content of cancer cells exposed to H/R and treated with melatonin corroborates other studies that have found antiproliferative and pro-apoptotic activity of melatonin, evident in both in vitro and in vivo models as well as in clinical assays for an array of diverse cancers [19, 42, 43].…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…We observe a reduction in mitochondrial content in melatonin treated BeWo cells exposed to H/R, which may indicate heightened levels of mitophagy, and which has been shown to be harmful for cancer cells [44, 45]. Our result showing the decreased mitochondrial content of cancer cells exposed to H/R and treated with melatonin corroborates other studies that have found antiproliferative and pro-apoptotic activity of melatonin, evident in both in vitro and in vivo models as well as in clinical assays for an array of diverse cancers [19, 42, 43].…”
Section: Discussionsupporting
confidence: 89%
“…Consequent to JNK inhibition, autophagy activation has been shown to be decreased in a hepatoma cell line [41]. Other studies indicate that the inhibitory effect of melatonin on autophagy may be mediated by the activation of endoplasmic reticulum (ER)-stress [42, 43]. The lack of variation in the levels of LC3B lipidation in melatonin-treated BeWo cells is not related to the lack of autophagic activity, but rather arises as a consequence of the active destruction of defective mitochondria via mitophagy [39].…”
Section: Discussionmentioning
confidence: 99%
“…Valproic acid (VA) inhibits invasiveness of bladder cancer. When combined with melatonin, VA exhibits enhanced autophagy by triggering several autophagic genes including Beclin1, Atg3 and Atg5 [143]. Collectively, the results support the use of melatonin as a chemotherapeutic in the treatment of these tumors of the gastrointestinal system due to their ability to enhance cancer cell autophagy.…”
Section: Autophagysupporting
confidence: 58%
“…It has been documented that melatonin modulates the signalling of neuronal cell death [47] and bladder cancer cells induced by ERS [48]. Melatonin significantly reverses tunicamycin-induced ERS in human hepatocellular carcinoma cells and improves cytotoxic responses to doxorubicin by increasing the expression of CHOP [49].…”
Section: Discussionmentioning
confidence: 99%